Buy Vision Essence Early Defence 180 capsules (6mth)

Buy Vision Essence Early Defence is for macular degeneration support

Vision Essence does not contain Zinc and is different than an AREDS2 style vitamin for macular degeneration treatment.

What does Early Defence actually do? 

At risk for macular degeneration?  Diagnosed with AMD? It is critical that you improve your protective macular pigment.  The goal of a macular supplement like Early Defence is to build this protective pigment.  Think of macular pigment as 'sunglasses' for your retina.  Building macular pigment density through lutein (and related carotenoid) supplementation reduces glare and and by absorbing this energy, can reduce chronic damage to the retina.   Although it is recommended for those with / or at risk for AMD (Macular Degeneration), it is valuable for any adult -   especially diabetics or those with fair skin and light eyes.

Buy Early Defence for its three critical carotenoids to build macular pigment: Meso-Zeaxanthin (10mg), Lutein (10mg) and Zeaxanthin (2mg).

• Guaranteed for label content and purity - Independently certified by ISO accredited testing labs (International Standards Organization) 
• Safety and stability reviewed annually by Health Canada to ensure product integrity 
• VEGAN, does not contains Zinc and never contains - Soy, Egg, Gluten, Animal Gelatin, PVP, Artificial colours or sweeteners.

** Expiration date now printed on the bottle of the bottle (not on label)

BUY VISION ESSENCE and IT ALWAYS SHIPS FREE TO CANADA - Minimum purchase not required

Alternate spelling of 'Early Defence' is 'Early Defense'

One 180 capsule bottles of Early Defence - Vision Essence  (6 month supply)

Also available in 90 capsule bottles and annual supply bundle

Take with food for maximum absorption.

AUG 2023 Update:  Vision Essence has changed their formulation to be more bioavailable - These new soft gels look different than old stock  Find out more...

Why Macular Pigment Density Matters for Long-Term Vision

Macular pigment density is increasingly recognized as a measurable and modifiable factor in long-term retinal health. The macula is constantly exposed to high-energy visible (blue) light. Over time, this exposure contributes to oxidative stress within retinal tissues, particularly in individuals with low baseline macular pigment.

Dietary intake of macular carotenoids is highly variable, and many adults do not consume sufficient lutein, zeaxanthin, and meso-zeaxanthin through food alone. Supplementation provides a predictable and standardized method of increasing macular pigment levels. Clinical research has demonstrated that higher macular pigment density is associated with improved visual comfort, reduced glare sensitivity, and better contrast perception.

Individuals with age-related macular degeneration, diabetes, cardiovascular risk factors, or significant cumulative light exposure may have an increased demand for protective carotenoids. Genetics, lifestyle, and absorption efficiency also play a role. Vision Essence Early Defence is formulated specifically to address these variables by supplying all three macular carotenoids in a balanced ratio designed to support pigment accumulation across the macula.

Vision Essence Early Defence vs Traditional AREDS-Style Supplements

AREDS and AREDS2 formulations were designed for specific stages of age-related macular degeneration and include zinc as a core component. While effective for many patients, zinc-containing supplements are not appropriate for everyone. Some individuals experience gastrointestinal intolerance, copper imbalance concerns, or have been advised by their eye care professional to avoid zinc.

Early Defence is fundamentally different in both purpose and formulation. Rather than functioning as a high-dose antioxidant formula, it focuses specifically on macular pigment optimization. By excluding zinc and emphasizing targeted carotenoid delivery, it offers an alternative approach for individuals who are not candidates for AREDS-style products or who are in earlier stages of risk management.

This formulation may be particularly appropriate for patients seeking proactive macular support, those monitoring macular pigment density, or individuals advised to avoid zinc supplementation. Early Defence can also be considered as part of a broader eye-health strategy under the guidance of an optometrist or ophthalmologist, especially when macular pigment support is the primary objective rather than late-stage disease intervention.